![Eric Halioua](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Halioua
Président chez
BIOSENIC SA
Profil
Eric Halioua was the founder of MYOSIX SA, founded in 2000, where the title held was Chief Executive Officer in 2002.
Mr. Halioua was the founder of PROMETHERA Biosciences SA, founded in 2009, where the title held was Chief Executive Officer from 2009 to 2015.
Mr. Halioua is also the founder of Murigenetics SAS..
Mr. Halioua is currently Co-President, Chief Executive Officer & Director at PDC Line Pharma SASU since 2016.
Mr. Halioua is Chairman at BioSenic SA starting in 2025.
Mr. Halioua is Director at European Biopharmaceutical Enterprises.
Mr. Halioua is Director at BioCuster.
Former positions include Chairman & Chief Executive Officer at PDC Line Pharma SA, Director at Vivalis SA, Non-Executive Director at Bioxodes SA, Project Leader at AstraZeneca PLC, and Principal at Arthur D.
Little, Inc. Education includes graduate degrees from ESSEC Business School and Université des Sciences et Technologies de Lille.
Postes actifs de Eric Halioua
| Sociétés | Poste | Début |
|---|---|---|
| BIOSENIC SA | Président | 01/09/2025 |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Directeur/Membre du Conseil | - |
BioCuster | Directeur/Membre du Conseil | - |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Directeur Général | 01/04/2016 |
Anciens postes connus de Eric Halioua
| Sociétés | Poste | Fin |
|---|---|---|
PDC Line Pharma SA
 PDC Line Pharma SA Pharmaceuticals: MajorHealth Technology Develops cancer immunotherapies solutions | Directeur Général | 10/12/2021 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Directeur Général | 23/01/2015 |
MYOSIX SA
 MYOSIX SA BiotechnologyHealth Technology Develops cell-based therapeutics | Directeur Général | 01/01/2002 |
Bioxodes SA
 Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Directeur/Membre du Conseil | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Eric Halioua
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Manufactures human and animal vaccines | Health Technology |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
MYOSIX SA
MYOSIX SA BiotechnologyHealth Technology Develops cell-based therapeutics | Health Technology |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université des Sciences et Technologies de Lille
 Université des Sciences et Technologies de Lille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
Murigenetics SAS | |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Health Technology |
BioCuster | |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Health Technology |
PDC Line Pharma SA
PDC Line Pharma SA Pharmaceuticals: MajorHealth Technology Develops cancer immunotherapies solutions | Health Technology |
BioSenic SA
 BioSenic SA BiotechnologyHealth Technology Engages in medical research and develops drugs | Health Technology |
